Mar 22, 2018
Jin Zhang looks at the Chinese pharma companies that received FDA ANDA approvals in 2017 and discusses how the country's industry is poised for further breakthrough.
Mar 21, 2018
Looking back at the agenda of a 1985 EFPIA conference, Reflector sees that, three decades on, the European drug industry is still seeking a pill for its own ills.
Mar 01, 2018
Jin Zhang outlines four key areas that impacted Chinese pharma in 2017 and looks at how their effects will shape the industry in the years ahead.
Feb 20, 2018
In the coming weeks, the EU will decide if the degree of protection offered to drug firms by research incentives such as the SPC are really in the interests of patients and society. Reflector reports.
Feb 11, 2018
Jin Zhang reviews the current fortunes of the Chinese pharmaceutical companies.
Feb 06, 2018
Pharmaceutical Executive
Julian Upton assembles a few rare slivers of positivity on UK pharma's future.
Feb 04, 2018
Professor Carole Longson's move from NICE to the ABPI is another appointment that helps to square the balance between UK industry and Government. Leela Barham reports.
Feb 03, 2018
The UK's NICE now has the job of both being a member of the newly named Accelerated Access Collaborative (AAC) and also acting as its Secretariat.
Jan 30, 2018
As the Ukranian healthcare market opens up to more public and private competition, it will become more attractive for investors — both Ukrainian and foreign, write Lana Sinichkina and Anna Zorya.
Jan 29, 2018
Outlining the procedures to manage anti-corruption risk that life sciences companies should consider before doing business in China.
lorem ipsum